BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim W, Conery AL, Rajamuthiah R, Fuchs BB, Ausubel FM, Mylonakis E. Identification of an Antimicrobial Agent Effective against Methicillin-Resistant Staphylococcus aureus Persisters Using a Fluorescence-Based Screening Strategy. PLoS One 2015;10:e0127640. [PMID: 26039584 DOI: 10.1371/journal.pone.0127640] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Felix L, Mishra B, Khader R, Ganesan N, Mylonakis E. In Vitro and In Vivo Bactericidal and Antibiofilm Efficacy of Alpha Mangostin Against Staphylococcus aureus Persister Cells. Front Cell Infect Microbiol 2022;12:898794. [DOI: 10.3389/fcimb.2022.898794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Alves NSF, Kaory Inoue SG, Carneiro AR, Albino UB, Setzer WN, Maia JG, Andrade EH, da Silva JKR. Variation in Peperomia pellucida growth and secondary metabolism after rhizobacteria inoculation. PLoS One 2022;17:e0262794. [PMID: 35061852 DOI: 10.1371/journal.pone.0262794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hamad M, Al-Marzooq F, Srinivasulu V, Omar HA, Sulaiman A, Zaher DM, Orive G, Al-Tel TH. Antibacterial Activity of Small Molecules Which Eradicate Methicillin-Resistant Staphylococcus aureus Persisters. Front Microbiol 2022;13:823394. [PMID: 35178043 DOI: 10.3389/fmicb.2022.823394] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Van den Bergh B. Bugs on Drugs: A Drosophila melanogaster Gut Model to Study In Vivo Antibiotic Tolerance of E. coli. Microorganisms 2022;10:119. [PMID: 35056568 DOI: 10.3390/microorganisms10010119] [Reference Citation Analysis]
5 Schrank CL, Wilt IK, Monteagudo Ortiz C, Haney BA, Wuest WM. Using membrane perturbing small molecules to target chronic persistent infections. RSC Med Chem 2021;12:1312-24. [PMID: 34458737 DOI: 10.1039/d1md00151e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kuehl R, Morata L, Meylan S, Mensa J, Soriano A. When antibiotics fail: a clinical and microbiological perspective on antibiotic tolerance and persistence of Staphylococcus aureus. J Antimicrob Chemother 2020;75:1071-86. [PMID: 32016348 DOI: 10.1093/jac/dkz559] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
7 Solís-Salas LM, Sierra-Rivera CA, Cobos-Puc LE, Ascacio-Valdés JA, Silva-Belmares SY. Antibacterial Potential by Rupture Membrane and Antioxidant Capacity of Purified Phenolic Fractions of Persea americana Leaf Extract. Antibiotics (Basel) 2021;10:508. [PMID: 33946930 DOI: 10.3390/antibiotics10050508] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Felix L, Mylonakis E, Fuchs BB. Thioredoxin Reductase Is a Valid Target for Antimicrobial Therapeutic Development Against Gram-Positive Bacteria. Front Microbiol 2021;12:663481. [PMID: 33936021 DOI: 10.3389/fmicb.2021.663481] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
9 Peng J, Mishra B, Khader R, Felix L, Mylonakis E. Novel Cecropin-4 Derived Peptides against Methicillin-Resistant Staphylococcus aureus. Antibiotics (Basel) 2021;10:36. [PMID: 33401476 DOI: 10.3390/antibiotics10010036] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
10 Li X, Wang P, Hu X, Zhang Y, Lu X, Li C, Nie T, Li G, Wang X, Pang J, Lu Y, Yang X, You X. The combined antibacterial effects of sodium new houttuyfonate and berberine chloride against growing and persistent methicillin-resistant and vancomycin-intermediate Staphylococcus aureus. BMC Microbiol 2020;20:317. [PMID: 33076836 DOI: 10.1186/s12866-020-02003-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
11 Khan F, Pham DTN, Tabassum N, Oloketuyi SF, Kim Y. Treatment strategies targeting persister cell formation in bacterial pathogens. Critical Reviews in Microbiology 2020;46:665-88. [DOI: 10.1080/1040841x.2020.1822278] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
12 Escobar IE, White A, Kim W, Mylonakis E. New Antimicrobial Bioactivity against Multidrug-Resistant Gram-Positive Bacteria of Kinase Inhibitor IMD0354. Antibiotics (Basel) 2020;9:E665. [PMID: 33019726 DOI: 10.3390/antibiotics9100665] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
13 Salcedo-Sora JE, Kell DB. A Quantitative Survey of Bacterial Persistence in the Presence of Antibiotics: Towards Antipersister Antimicrobial Discovery. Antibiotics (Basel) 2020;9:E508. [PMID: 32823501 DOI: 10.3390/antibiotics9080508] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
14 Kim W, Zou G, Pan W, Fricke N, Faizi HA, Kim SM, Khader R, Li S, Lee K, Escorba I, Vlahovska PM, Gao H, Ausubel FM, Mylonakis E. The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant Staphylococcus aureus. mBio 2020;11:e01140-20. [PMID: 32605985 DOI: 10.1128/mBio.01140-20] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
15 Kim SM, Escorbar I, Lee K, Fuchs BB, Mylonakis E, Kim W. Anti-MRSA agent discovery using Caenorhabditis elegans-based high-throughput screening. J Microbiol 2020;58:431-44. [PMID: 32462486 DOI: 10.1007/s12275-020-0163-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
16 Uzoechi SC, Abu-Lail NI. Variations in the Morphology, Mechanics and Adhesion of Persister and Resister E. coli Cells in Response to Ampicillin: AFM Study. Antibiotics (Basel) 2020;9:E235. [PMID: 32392749 DOI: 10.3390/antibiotics9050235] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
17 Singh AK, Mishra H, Firdaus Z, Yadav S, Aditi P, Nandy N, Sharma K, Bose P, Pandey AK, Chauhan BS, Neogi K, Vikram K, Srivastava A, Kar AG, Prakash P. MoS2-Modified Curcumin Nanostructures: The Novel Theranostic Hybrid Having Potent Antibacterial and Antibiofilm Activities against Multidrug-Resistant Hypervirulent Klebsiella pneumoniae. Chem Res Toxicol 2019;32:1599-618. [PMID: 31315397 DOI: 10.1021/acs.chemrestox.9b00135] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
18 Kim W, Zou G, Hari TPA, Wilt IK, Zhu W, Galle N, Faizi HA, Hendricks GL, Tori K, Pan W, Huang X, Steele AD, Csatary EE, Dekarske MM, Rosen JL, Ribeiro NQ, Lee K, Port J, Fuchs BB, Vlahovska PM, Wuest WM, Gao H, Ausubel FM, Mylonakis E. A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A 2019;116:16529-34. [PMID: 31358625 DOI: 10.1073/pnas.1904700116] [Cited by in Crossref: 35] [Cited by in F6Publishing: 55] [Article Influence: 11.7] [Reference Citation Analysis]
19 Nicolas I, Bordeau V, Bondon A, Baudy-Floc'h M, Felden B. Novel antibiotics effective against gram-positive and -negative multi-resistant bacteria with limited resistance. PLoS Biol 2019;17:e3000337. [PMID: 31287812 DOI: 10.1371/journal.pbio.3000337] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
20 van Tatenhove-Pel RJ, Zwering E, Solopova A, Kuipers OP, Bachmann H. Ampicillin-treated Lactococcus lactis MG1363 populations contain persisters as well as viable but non-culturable cells. Sci Rep 2019;9:9867. [PMID: 31285492 DOI: 10.1038/s41598-019-46344-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
21 Antonoplis A, Zang X, Huttner MA, Chong KKL, Lee YB, Co JY, Amieva MR, Kline KA, Wender PA, Cegelski L. A Dual-Function Antibiotic-Transporter Conjugate Exhibits Superior Activity in Sterilizing MRSA Biofilms and Killing Persister Cells. J Am Chem Soc 2018;140:16140-51. [PMID: 30388366 DOI: 10.1021/jacs.8b08711] [Cited by in Crossref: 55] [Cited by in F6Publishing: 67] [Article Influence: 13.8] [Reference Citation Analysis]
22 Trastoy R, Manso T, Fernández-García L, Blasco L, Ambroa A, Pérez Del Molino ML, Bou G, García-Contreras R, Wood TK, Tomás M. Mechanisms of Bacterial Tolerance and Persistence in the Gastrointestinal and Respiratory Environments. Clin Microbiol Rev 2018;31:e00023-18. [PMID: 30068737 DOI: 10.1128/CMR.00023-18] [Cited by in Crossref: 61] [Cited by in F6Publishing: 72] [Article Influence: 15.3] [Reference Citation Analysis]
23 Liu Q, Zheng Z, Kim W, Burgwyn Fuchs B, Mylonakis E. Influence of subinhibitory concentrations of NH125 on biofilm formation & virulence factors of Staphylococcus aureus. Future Med Chem 2018;10:1319-31. [PMID: 29846088 DOI: 10.4155/fmc-2017-0286] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
24 Defraine V, Fauvart M, Michiels J. Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics. Drug Resistance Updates 2018;38:12-26. [DOI: 10.1016/j.drup.2018.03.002] [Cited by in Crossref: 96] [Cited by in F6Publishing: 94] [Article Influence: 24.0] [Reference Citation Analysis]
25 Kalita S, Kandimalla R, Bhowal AC, Kotoky J, Kundu S. Functionalization of β-lactam antibiotic on lysozyme capped gold nanoclusters retrogress MRSA and its persisters following awakening. Sci Rep 2018;8:5778. [PMID: 29636496 DOI: 10.1038/s41598-018-22736-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 10.0] [Reference Citation Analysis]
26 Basak A, Abouelhassan Y, Zuo R, Yousaf H, Ding Y, Huigens RW. Antimicrobial peptide-inspired NH125 analogues: bacterial and fungal biofilm-eradicating agents and rapid killers of MRSA persisters. Org Biomol Chem 2017;15:5503-12. [PMID: 28534905 DOI: 10.1039/c7ob01028a] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
27 Kim W, Hendricks GL, Tori K, Fuchs BB, Mylonakis E. Strategies against methicillin-resistant Staphylococcus aureus persisters. Future Med Chem 2018;10:779-94. [PMID: 29569952 DOI: 10.4155/fmc-2017-0199] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
28 Tharmalingam N, Port J, Castillo D, Mylonakis E. Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori. Sci Rep 2018;8:3701. [PMID: 29487357 DOI: 10.1038/s41598-018-22037-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 11.8] [Reference Citation Analysis]
29 Tharmalingam N, Rajmuthiah R, Kim W, Fuchs BB, Jeyamani E, Kelso MJ, Mylonakis E. Antibacterial Properties of Four Novel Hit Compounds from a Methicillin-Resistant Staphylococcus aureus-Caenorhabditis elegans High-Throughput Screen. Microb Drug Resist 2018;24:666-74. [PMID: 29461939 DOI: 10.1089/mdr.2017.0250] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
30 Zheng Z, Liu Q, Kim W, Tharmalingam N, Fuchs BB, Mylonakis E. Antimicrobial activity of 1,3,4-oxadiazole derivatives against planktonic cells and biofilm of Staphylococcus aureus. Future Med Chem 2018;10:283-96. [PMID: 29334249 DOI: 10.4155/fmc-2017-0159] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
31 Liebens V, Defraine V, Knapen W, Swings T, Beullens S, Corbau R, Marchand A, Chaltin P, Fauvart M, Michiels J. Identification of 1-((2,4-Dichlorophenethyl)Amino)-3-Phenoxypropan-2-ol, a Novel Antibacterial Compound Active against Persisters of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2017;61:e00836-17. [PMID: 28630188 DOI: 10.1128/AAC.00836-17] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
32 Tharmalingam N, Jayamani E, Rajamuthiah R, Castillo D, Fuchs BB, Kelso MJ, Mylonakis E. Activity of a novel protonophore against methicillin-resistant Staphylococcus aureus. Future Med Chem 2017;9:1401-11. [PMID: 28771026 DOI: 10.4155/fmc-2017-0047] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
33 Kim W, Hendricks GL, Lee K, Mylonakis E. An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs. Expert Opin Drug Discov 2017;12:625-33. [PMID: 28402221 DOI: 10.1080/17460441.2017.1319358] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
34 Gominet M, Compain F, Beloin C, Lebeaux D. Central venous catheters and biofilms: where do we stand in 2017? APMIS 2017;125:365-75. [PMID: 28407421 DOI: 10.1111/apm.12665] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 13.2] [Reference Citation Analysis]
35 Van den Bergh B, Fauvart M, Michiels J. Formation, physiology, ecology, evolution and clinical importance of bacterial persisters. FEMS Microbiology Reviews 2017;41:219-51. [DOI: 10.1093/femsre/fux001] [Cited by in Crossref: 147] [Cited by in F6Publishing: 165] [Article Influence: 29.4] [Reference Citation Analysis]
36 Waters EM, Rowe SE, O'Gara JP, Conlon BP. Convergence of Staphylococcus aureus Persister and Biofilm Research: Can Biofilms Be Defined as Communities of Adherent Persister Cells? PLoS Pathog 2016;12:e1006012. [PMID: 28033390 DOI: 10.1371/journal.ppat.1006012] [Cited by in Crossref: 65] [Cited by in F6Publishing: 74] [Article Influence: 10.8] [Reference Citation Analysis]
37 Kong C, Eng SA, Lim MP, Nathan S. Beyond Traditional Antimicrobials: A Caenorhabditis elegans Model for Discovery of Novel Anti-infectives. Front Microbiol 2016;7:1956. [PMID: 27994583 DOI: 10.3389/fmicb.2016.01956] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
38 Stranava M, Martínek V, Man P, Fojtikova V, Kavan D, Vaněk O, Shimizu T, Martinkova M. Structural characterization of the heme-based oxygen sensor, AfGcHK, its interactions with the cognate response regulator, and their combined mechanism of action in a bacterial two-component signaling system. Proteins 2016;84:1375-89. [PMID: 27273553 DOI: 10.1002/prot.25083] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
39 Smith KP, Kirby JE. Validation of a High-Throughput Screening Assay for Identification of Adjunctive and Directly Acting Antimicrobials Targeting Carbapenem-Resistant Enterobacteriaceae. Assay Drug Dev Technol 2016;14:194-206. [PMID: 27045615 DOI: 10.1089/adt.2016.701] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
40 Kim W, Fricke N, Conery AL, Fuchs BB, Rajamuthiah R, Jayamani E, Vlahovska PM, Ausubel FM, Mylonakis E. NH125 kills methicillin-resistant Staphylococcus aureus persisters by lipid bilayer disruption. Future Med Chem 2016;8:257-69. [PMID: 26910612 DOI: 10.4155/fmc.15.189] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
41 Wood TK. Combatting bacterial persister cells. Biotechnol Bioeng 2016;113:476-83. [DOI: 10.1002/bit.25721] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 11.4] [Reference Citation Analysis]